Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > MEND > Summary

Micrus Endovascular Corp.
(MEND)

18.60USD   Up0.73 (4.09%)   
At 2:30AM IST
 Micrus Endovascular Corp. (NGM:MEND) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Last Trade: 18.60USD
Trade Time:2:30AM IST
Change:Up0.73 (4.09%)
Prev Close:17.87
Open:17.99
Bid:17.49 x 100
Ask:19.67 x 200
1y Target Est:17.02
Day's Range:17.89 - 18.78
52wk Range:4.13 - 18.78
Volume:252,682
Avg Vol (3m):93,071.4
Market Cap:297.71M
P/E (ttm):71.54
EPS (ttm):0.26
Div & Yield:N/A (N/A%)
Add MEND to Portfolio   Download Data

HEADLINES

 
•Micrus Endovascular (MEND): Zacks Rank Buy - Zacks.com  - Mon, Feb 8
•New Star Analyst Rankings for Micrus Endovascular Corporation - StarMine  - Sat, Feb 6
•MICRUS ENDOVASCULAR CORP Files SEC form 10-Q, Quarterly Report - EDGAR Online  - Sat, Feb 6
•Micrus Endovascular reports fiscal 3rd-qtr profit - AP  - Fri, Feb 5
•Micrus moves from Q3 loss to $3.3M profit - bizjournals.com  - Thu, Feb 4
•MICRUS ENDOVASCULAR CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and - EDGAR Online  - Thu, Feb 4
•Micrus Endovascular Reports Fiscal Third Quarter Revenues of $22.8 Million and Diluted EPS of $0.20 - Business Wire  - Thu, Feb 4
•Micrus Endovascular to Hold Fiscal 2010 Third Quarter Conference Call on February 4 - Business Wire  - Thu, Jan 28
•Cashing In on Obamacare - Motley Fool  - Fri, Jan 22
•Helen of Troy Ltd. (HELE): Zacks Rank Buy - Zacks.com  - Mon, Jan 18
•Zacks Releases Four Powerful ''Buy'' Stocks: Encore Capital Group, Inc., Harris Corp., Micrus Endovascular Corp. and Whirlpool Corporation - Zacks.com  - Thu, Jan 14
•Micrus Endovascular Corp. (MEND): Zacks Rank Buy - Zacks.com  - Thu, Jan 14
•Coverage initiated on Micrus Endovascular by Rodman & Renshaw - Briefing.com  - Fri, Jan 8
•Micrus Endovascular to Present at January Investment Conferences - Business Wire  - Tue, Jan 5
» More Headlines for MEND...

ANALYST

 
EPS Est (next year) (Mar-10) :0.52
EPS Est (in 2 years) (Mar-11) :0.58
Avg Rec (current)*:1.6
PEG Ratio:0.74
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Micrus Endovascular Corporation develops, manufactures, and markets implantable and disposable medical devices to treat cerebral vascular diseases. It offers MicruSphere Microcoil, a framing coil that stabilizes the aneurysm; Presidio Microcoil, a...

» Full Company Profile